Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Mesa Laboratories (MLAB) stocks in Canada

Learn how to easily invest in Mesa Laboratories stocks.

Mesa Laboratories is a scientific & technical instruments business based in the US. Mesa Laboratories stocks (MLAB.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $277.8 – a decrease of 4.72% over the previous week. Mesa Laboratories employs 506 staff and has a trailing 12-month revenue of around $142.9 million.

How to buy shares in Mesa Laboratories

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MLAB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Mesa Laboratories stock price (NASDAQ:MLAB)

Use our graph to track the performance of MLAB stocks over time.

Mesa Laboratories shares at a glance

Information last updated 2022-01-25.
Latest market close$279.33
52-week range$232.47 - $333.42
50-day moving average $314.39
200-day moving average $286.85
Wall St. target price$331.67
PE ratio 307.2351
Dividend yield $0.64 (0.21%)
Earnings per share (TTM) $0.95

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Mesa Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Mesa Laboratories price performance over time

Historical closes compared with the close of $279.33 from 2022-01-26

1 week (2022-01-21) -5.10%
1 month (2021-12-28) -15.58%
3 months (2021-10-28) -8.10%
6 months (2021-07-28) -2.49%
1 year (2021-01-28) -1.30%
2 years (2020-01-27) 5.69%
3 years (2019-01-25) 26.96%
5 years (2017-01-27) 133.36%

Is Mesa Laboratories under- or over-valued?

Valuing Mesa Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mesa Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Mesa Laboratories's P/E ratio

Mesa Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 307x. In other words, Mesa Laboratories shares trade at around 307x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Mesa Laboratories's EBITDA

Mesa Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $29.5 million.

The EBITDA is a measure of a Mesa Laboratories's overall financial performance and is widely used to measure a its profitability.

Mesa Laboratories financials

Revenue TTM $142.9 million
Operating margin TTM 7.91%
Gross profit TTM $86.6 million
Return on assets TTM 1.18%
Return on equity TTM 1.29%
Profit margin 3.56%
Book value $76.47
Market capitalisation $1.5 billion

TTM: trailing 12 months

Mesa Laboratories share dividends


Dividend payout ratio: 12.11% of net profits

Recently Mesa Laboratories has paid out, on average, around 12.11% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Mesa Laboratories shareholders could enjoy a 0.21% return on their shares, in the form of dividend payments. In Mesa Laboratories's case, that would currently equate to about $0.64 per share.

While Mesa Laboratories's payout ratio might seem low, this can signify that Mesa Laboratories is investing more in its future growth.

Mesa Laboratories's most recent dividend payout was on 14 March 2022. The latest dividend was paid out to all shareholders who bought their shares by 24 February 2022 (the "ex-dividend date").

Mesa Laboratories share price volatility

Over the last 12 months, Mesa Laboratories's shares have ranged in value from as little as $232.4741 up to $333.42. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mesa Laboratories's is 0.3457. This would suggest that Mesa Laboratories's shares are less volatile than average (for this exchange).

Mesa Laboratories overview

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site